Energy News / Shareholders Foundation, Inc.

NASDAW:EDGE Shareholder Notice: Deadline on June 22, 2018 in Lawsuit Against Edge Therapeutics, Inc

Via: ReleaseWire

Updated 11:00 AM CDT, Wed, June 20,2018

A Deadline is coming up on June 22, 2018 in the lawsuit for investors in Edge Therapeutics, Inc. (NASDAW:EDGE) and NASDAW:EDGE stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWIRE) -- 06/20/2018 -- A deadline is coming up on June 22, 2018 in the lawsuit filed for certain investors in NASDAW:EDGE shares over alleged securities laws violations by Edge Therapeutics, Inc.

Investors who purchased shares of Edge Therapeutics, Inc. (NASDAW:EDGE) have certain options and there are strict and short deadlines running. Deadline: June 22, 2018. NASDAW:EDGE stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiff alleges on behalf of purchasers of Edge Therapeutics, Inc. (NASDAW:EDGE) common shares between December 29, 2017 and March 27, 2018, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between December 29, 2017 and March 27, 2018, the Defendants failed to disclose that the Company's lead product candidate EG-1962 would likely fail a futility analysis in connection with the NEWTON 2 study, and that, as a result of the foregoing, the Company's financial statements and Defendants' statements about Edge's business, operations, and prospects, were materially false and misleading at all relevant times.

Those who purchased shares of Edge Therapeutics, Inc. (NASDAW:EDGE) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdawedge-shareholder-notice-deadline-on-june-22-2018-in-lawsuit-against-edge-therapeutics-inc-997798.htm

Media Relations Contact
Michael Daniels
858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com